User menu

Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial

Bibliographic reference Coudert, B. ; Campone, M. ; Spielmann, M. ; Symann, Michel ; Eichler, F. ; et. al. Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial.32nd Annual San Antonio Breast Cancer Symposium (San Antonio (Tx), Dec 09-13, 2009). In: Cancer Research, Vol. 69, no. 24, p. 522S-522S (2009)
Permanent URL http://hdl.handle.net/2078.1/58646